Calantric™ Digital Solutions reportedly offers artificial intelligence (AI)-powered apps, bolsters lesion detection, facilitates triage priorities and enhances workflow efficiency.
Could a new cloud-based suite of imaging apps help radiologists navigate increasing imaging volume in their practices?
Calantric Digital Solutions offer apps that target three key aspects of radiology workflow, according to Bayer, the manufacturer of the new platform. The company said the system includes apps to assist with lesion detection, triage of suspicious findings for expedited review, and automation of routine tasks and measurements.
The artificial intelligence (AI)-powered aspects of the imaging app platform and access to digital tools may be beneficial in improving diagnostic accuracy and efficiency with imaging assessment, according to Ryan K. Lee, MD, MBA, MRMD, chair of the department of radiology with Einstein Healthcare Network in Philadelphia
“AI has the potential to transform health care, and, particularly in medical imaging, it can turn the growing amounts of data into value-adding insights to support radiologists and their teams in their decision-making,” noted Dr. Lee, an associate professor at the Sydney Kimmel College at Thomas Jefferson University.
Offering a variety of applications, ranging from assistance with pulmonary nodule detection to triage of suspected intracerebral hemorrhage, the initial platform for Calantric Digital Solutions is primarily focused on the assessment of thoracic and neurological diseases, according to Bayer. However, the company said it plans to add more disease-specific apps to the platform in the future.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.